Back to Agenda
Paediatric Policy Initiatives: Globalisation of Paediatric Drug Development Best Practice or Imperialism of Practice?
Session Chair(s)
Christina Bucci-Rechtweg, MD
Global Head, Maternal Health and Pediatric Regulatory Policy
Novartis , United States
Paediatric legislation implementing a system of obligations and rewards has led to a significant increase in paediatric studies. Whilst studies conducted are multinational, regional regulatory objectives may not serve global research needs. This session will utilise a series of cases which highlight the global nature of paediatric drug development.
Speaker(s)
Panel Discussion
Julia Bielicki
University Children's Hospital Basel, Switzerland
Attending Physician Pediatrics & Pediatric Infectious Diseases,
Panel Discussion
Angelika Joos, MPharm
MSD, Belgium
Executive Director, Science & Regulatory Policy
Panel Discussion
Frank Van den Ouweland, DrMed, PhD
Switzerland
Free-lance consultant
Panel Discussion
Cesare Spadoni
aPODD Foundation, United Kingdom
Founder and Chairman of the Board
Have an account?